Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6)

Elise Wreven; María Soledad Ruiz de Adana; Stéphan Hardivillé; Valery Gmyr; Julie Kerr-Conte; Mikael Chetboun; Gianni Pasquetti; Nathalie Delalleau; Julien Thévenet; Anaïs Coddeville; María José Vallejo Herrera; Liad Hinden; Inmaculada Concepción Benavides Espínola; Mireia Gómez Duro; Lourdes Sanchez Salido; Francisca Linares; Francisco Javier Bermúdez-Silva; Joseph Tam; Caroline Bonner; Josephine M. Egan; Gabriel Olveira; Natalia Colomo; François Pattou; Isabel González-Mariscal

doi:10.1007/s00125-025-06372-z

Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6)

Elise Wreven
, María Soledad Ruiz de Adana
, Stéphan Hardivillé
, Valery Gmyr
, Julie Kerr-Conte
, Mikael Chetboun
, Gianni Pasquetti
, Nathalie Delalleau
, Julien Thévenet
, Anaïs Coddeville
, María José Vallejo Herrera
, Liad Hinden
, Inmaculada Concepción Benavides Espínola
, Mireia Gómez Duro
, Lourdes Sanchez Salido
, Francisca Linares
, Francisco Javier Bermúdez-Silva
, Joseph Tam
, Caroline Bonner
, Josephine M. Egan

Gabriel Olveira, Natalia Colomo, François Pattou, Isabel González-Mariscal^*

^*Corresponding author for this work

School of Pharmacy

Research output: Contribution to journal › Comment/debate

Abstract

Acknowledgment of funding for the project PID2021-128926OA-I00 by MICIU/AEI/10.13039/501100011033 and UE was omitted in the Funding section. The original article has been corrected.

Original language	English
Pages (from-to)	902
Number of pages	1
Journal	Diabetologia
Volume	68
Issue number	4
DOIs	https://doi.org/10.1007/s00125-025-06372-z
State	Published - Apr 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00125-025-06372-z

Fingerprint

Dive into the research topics of 'Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6)'. Together they form a unique fingerprint.

Cite this

Wreven, E., de Adana, M. S. R., Hardivillé, S., Gmyr, V., Kerr-Conte, J., Chetboun, M., Pasquetti, G., Delalleau, N., Thévenet, J., Coddeville, A., Herrera, M. J. V., Hinden, L., Espínola, I. C. B., Duro, M. G., Salido, L. S., Linares, F., Bermúdez-Silva, F. J., Tam, J., Bonner, C., ... González-Mariscal, I. (2025). Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6). Diabetologia, 68(4), 902. https://doi.org/10.1007/s00125-025-06372-z

@article{fc7b0b817da8481fa887bdcc8fcd4900,

title = "Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6)",

abstract = "Acknowledgment of funding for the project PID2021-128926OA-I00 by MICIU/AEI/10.13039/501100011033 and UE was omitted in the Funding section. The original article has been corrected.",

author = "Elise Wreven and \{de Adana\}, \{Mar{\'i}a Soledad Ruiz\} and St{\'e}phan Hardivill{\'e} and Valery Gmyr and Julie Kerr-Conte and Mikael Chetboun and Gianni Pasquetti and Nathalie Delalleau and Julien Th{\'e}venet and Ana{\"i}s Coddeville and Herrera, \{Mar{\'i}a Jos{\'e} Vallejo\} and Liad Hinden and Esp{\'i}nola, \{Inmaculada Concepci{\'o}n Benavides\} and Duro, \{Mireia G{\'o}mez\} and Salido, \{Lourdes Sanchez\} and Francisca Linares and Berm{\'u}dez-Silva, \{Francisco Javier\} and Joseph Tam and Caroline Bonner and Egan, \{Josephine M.\} and Gabriel Olveira and Natalia Colomo and Fran{\c c}ois Pattou and Isabel Gonz{\'a}lez-Mariscal",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = apr,

doi = "10.1007/s00125-025-06372-z",

language = "אנגלית",

volume = "68",

pages = "902",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "4",

}

Wreven, E, de Adana, MSR, Hardivillé, S, Gmyr, V, Kerr-Conte, J, Chetboun, M, Pasquetti, G, Delalleau, N, Thévenet, J, Coddeville, A, Herrera, MJV, Hinden, L, Espínola, ICB, Duro, MG, Salido, LS, Linares, F, Bermúdez-Silva, FJ, Tam, J, Bonner, C, Egan, JM, Olveira, G, Colomo, N, Pattou, F & González-Mariscal, I 2025, 'Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6)', Diabetologia, vol. 68, no. 4, pp. 902. https://doi.org/10.1007/s00125-025-06372-z

Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6). / Wreven, Elise; de Adana, María Soledad Ruiz; Hardivillé, Stéphan et al.
In: Diabetologia, Vol. 68, No. 4, 04.2025, p. 902.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6)

AU - Wreven, Elise

AU - de Adana, María Soledad Ruiz

AU - Hardivillé, Stéphan

AU - Gmyr, Valery

AU - Kerr-Conte, Julie

AU - Chetboun, Mikael

AU - Pasquetti, Gianni

AU - Delalleau, Nathalie

AU - Thévenet, Julien

AU - Coddeville, Anaïs

AU - Herrera, María José Vallejo

AU - Hinden, Liad

AU - Espínola, Inmaculada Concepción Benavides

AU - Duro, Mireia Gómez

AU - Salido, Lourdes Sanchez

AU - Linares, Francisca

AU - Bermúdez-Silva, Francisco Javier

AU - Tam, Joseph

AU - Bonner, Caroline

AU - Egan, Josephine M.

AU - Olveira, Gabriel

AU - Colomo, Natalia

AU - Pattou, François

AU - González-Mariscal, Isabel

PY - 2025/4

Y1 - 2025/4

N2 - Acknowledgment of funding for the project PID2021-128926OA-I00 by MICIU/AEI/10.13039/501100011033 and UE was omitted in the Funding section. The original article has been corrected.

AB - Acknowledgment of funding for the project PID2021-128926OA-I00 by MICIU/AEI/10.13039/501100011033 and UE was omitted in the Funding section. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85218249304

U2 - 10.1007/s00125-025-06372-z

DO - 10.1007/s00125-025-06372-z

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 39954060

AN - SCOPUS:85218249304

SN - 0012-186X

VL - 68

SP - 902

JO - Diabetologia

JF - Diabetologia

IS - 4

ER -

Wreven E, de Adana MSR, Hardivillé S, Gmyr V, Kerr-Conte J, Chetboun M et al. Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6). Diabetologia. 2025 Apr;68(4):902. doi: 10.1007/s00125-025-06372-z

Correction to: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans (Diabetologia, (2024), 67, 9, (1877-1896), 10.1007/s00125-024-06193-6)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this